Industry-Funded Trials Often Use Improper Comparators, JAMA Editorial Says
Executive Summary
Industry-sponsored comparative trials are often ineffective at answering clinically relevant questions due to the use of substandard comparators, according to a commentary in the April 12 issue of the Journal of the American Medical Association.